19 min read Bussines Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021 August 6, 2021 Tammy D. Neff • Preliminary translational data validate UCARTCS1 as a promising potential therapy for relapsed orrefractory...
6 min read Bussines Gritstone Reports Second Quarter 2021 Financial Results and Business Update August 6, 2021 Tammy D. Neff GRANITE Phase 1/2 data of individualized neoantigen immunotherapy in advanced solid tumors accepted for...